The current price of WGS is $59.16 — it has decreased by 8.08% since the previous close. Data as of Nov 6, 2026.
WGS is down 14.78% over the past week, down 17.40% over the past month and down 57.41% over the past year. The price is below its 200-day moving average of $71.17.
Of the 8 analysts covering GeneDx Holdings Corp., 1 rates it a strong buy and 7 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
GeneDx Holdings Corp. has a market capitalization of $1.76B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, GeneDx Holdings Corp. posted earnings of $0.01 per share against an estimate of -$0.1879, beating expectations by 105.32%. Upcoming reports are listed in the earnings calendar.
GeneDx Holdings Corp. reported revenue of $114.44M in its most recent quarter, which has increased by 11.44% compared with the same quarter a year earlier. Analysts had expected $111.01M.
GeneDx Holdings Corp. has not paid any dividends over the past year.
In the latest trading session WGS moved between $58.83 and $66.35, a range of 12.72% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of GeneDx Holdings Corp. shows a sell rating today. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for GeneDx Holdings Corp. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks WGS has traded between $32.21 and $170.87. The current price is 65.38% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.